This company has been marked as potentially delisted and may not be actively trading. Biofrontera (BFRA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BFRA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Biofrontera says last patient completes treatment in Phase 3 study of AmeluzSeptember 16, 2025 | msn.comBiofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic ...September 16, 2025 | finance.yahoo.comBiofrontera announces last-patient-out in Phase 2b study of Ameluz topical gelAugust 25, 2025 | msn.comBiofrontera files to sell 13.6M shares of common stock by selling shareholdersJuly 16, 2025 | msn.comNach Zahlungskrise: Biofrontera in Leverkusen sichert US-Geschäft abJuly 2, 2025 | msn.comBiofrontera-Aktie steigt nach Umstrukturierungsvereinbarung mit Biofrontera AGJuly 2, 2025 | de.investing.comBiofrontera ADR Aktie | BFRA Kurs | Realtime - Investing.comJune 29, 2025 | de.investing.comBiofrontera AG: Verhandlungen mit Biofrontera Inc. gehen kommende Woche weiterJune 27, 2025 | finanznachrichten.deBiofrontera AG Extends Payment Deferral Amid Strategic NegotiationsJune 26, 2025 | tipranks.comBiofrontera in Gesprächen mit AG-Muttergesellschaft über mögliche FusionJune 11, 2025 | de.investing.comBiofrontera Inc. Negotiates Cooperation Changes with Biofrontera AGJune 11, 2025 | tipranks.comBiofrontera AG verhandelt über grundlegende Änderungen ihrer Zusammenarbeit mit der Biofrontera Inc.June 10, 2025 | finanznachrichten.deBiofrontera AG Pre-announces H1 2025 Financial ReportJune 10, 2025 | tipranks.comBiofrontera AG Explores Strategic Changes with Biofrontera Inc.June 10, 2025 | tipranks.comBiofrontera AG’s Q1 2025 Earnings Call HighlightsMay 27, 2025 | tipranks.comBiofrontera AG Faces Financial Uncertainty Amid Biofrontera Inc. Payment IssuesMay 27, 2025 | tipranks.comBiofrontera Inc. (NASDAQ:BFRI) Q1 2025 Earnings Call TranscriptMay 20, 2025 | msn.comQ1 2025 Biofrontera Inc Earnings CallMay 17, 2025 | finance.yahoo.comBiofrontera verlängert Ameluz-Patent für Aknebehandlung bis 2043May 15, 2025 | de.investing.comBiofrontera Inc. droht Delisting von der Nasdaq wegen AktienkursMay 15, 2025 | de.investing.comBiofrontera AG’s Earnings Call Highlights Growth and Strategic AdvancesApril 23, 2025 | tipranks.comBiofrontera Full Year 2024 Earnings: €0.72 loss per share (vs €0.12 loss in FY 2023)April 18, 2025 | finance.yahoo.comBiofrontera AG Prepares to Release 2024 Financial ReportApril 17, 2025 | tipranks.comBiofrontera AG Reports 2024 Financial Results and Strategic Growth PlansApril 14, 2025 | tipranks.comBiofrontera AG Meets 2024 Forecasts and Outlines 2025 Financial ExpectationsApril 14, 2025 | tipranks.comBenchmark behält Kaufempfehlung für Biofrontera-Aktie bei, Kursziel 7 US-DollarMarch 24, 2025 | de.investing.comBiofrontera Inc. reports Q4 EPS (19c) vs $1.65 last yearMarch 22, 2025 | markets.businessinsider.comQ4 2024 Biofrontera Inc Earnings CallMarch 22, 2025 | finance.yahoo.comEarnings Call Transkript: Biofrontera verzeichnet Umsatzwachstum und strategische Veränderungen in Q4 2024March 21, 2025 | de.investing.comBiofrontera completes patient enrollment in Phase 3 study of AmeluzMarch 19, 2025 | markets.businessinsider.comBiofrontera enrols all subjects in trial of topical gel for actinic keratosesMarch 19, 2025 | msn.comBiofrontera says last patient completed one-year follow-up in Ameluz-PDT studyJanuary 9, 2025 | markets.businessinsider.comPTA-News: Biofrontera AG: BIOFRONTERA BERICHTET ÜBER DIE ERGEBNISSE DER ERSTEN NEUN MONATE DES JAHRES 2024November 29, 2024 | finanznachrichten.dePTA-News: Biofrontera AG: BIOFRONTERA BERICHTET -2-November 29, 2024 | finanznachrichten.deTelefonkonferenz zu den Quartalszahlen: Biofrontera verzeichnet moderates Umsatzwachstum im dritten Quartal 2024November 16, 2024 | de.investing.comBiofrontera stock climbs as drug-device succeeds in Phase III skin cancer trialNovember 1, 2024 | msn.comBiofrontera vermeldet Durchbruch in der Behandlung von HautkrebsOctober 31, 2024 | de.investing.comBiofrontera announces results in Phase 3 study of Ameluz-PDT for sBCCOctober 31, 2024 | markets.businessinsider.comRosalind Advisors, Inc. Reduces Stake in Biofrontera IncOctober 23, 2024 | uk.finance.yahoo.comLeverkusener Unternehmen: Wie Biofrontera sein Gewicht auf dem Pharma-Markt erhöhen willOctober 16, 2024 | msn.comBiofrontera schließt Datenbank der Phase-3-Studie zu sBCC für AnalyseOctober 15, 2024 | de.investing.comRoth/MKM setzt Kursziel für Biofrontera bei 16 US-Dollar, bekräftigt KaufempfehlungOctober 8, 2024 | de.investing.comBiofrontera (NASDAQ:BFRI) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comBiofrontera Second Quarter 2024 Earnings: €0.023 loss per share (vs €0.12 profit in 2Q 2023)October 2, 2024 | finance.yahoo.comBiofrontera Inc.: Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities ConferenceSeptember 25, 2024 | finanznachrichten.dePTA-News: Biofrontera AG: Erfolgreiche Hauptversammlung mit umfassender Zustimmung und neuen AufsichtsratsmitgliedernAugust 31, 2024 | finanznachrichten.deBiofrontera Inc. (BFRI) latest stock news & headlines – Yahoo FinanceAugust 27, 2024 | sg.finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.comBenchmark Co. Reaffirms Their Buy Rating on Biofrontera (BFRI)August 16, 2024 | markets.businessinsider.comPTA-Adhoc: Biofrontera AG: Rechtsstreit um Import in die USA und daraus resultierende PrognoseJuly 21, 2024 | finanznachrichten.de Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BFRA Media Mentions By Week BFRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BFRA News Sentiment▼0.330.79▲Average Medical News Sentiment BFRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BFRA Articles This Week▼20▲BFRA Articles Average Week Get the Latest News and Ratings for BFRA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biofrontera and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AVTE News BIOA News CYBN News VIRI News OSTX News ELYM News ATNM News EGRX News AADI News PYRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BFRA) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
